| Year |
Citation |
Score |
| 2023 |
Kleczko EK, Poczobutt JM, Navarro AC, Laskowski J, Johnson AM, Korpela SP, Gurule NJ, Heasley LE, Hopp K, Weiser-Evans MCM, Gottlin EB, Bushey RT, Campa MJ, Patz EF, Thurman JM, et al. Upregulation of complement proteins in lung cancer cells mediates tumor progression. Frontiers in Oncology. 12: 1045690. PMID 36686777 DOI: 10.3389/fonc.2022.1045690 |
0.393 |
|
| 2020 |
Johnson AM, Bullock BL, Neuwelt AJ, Poczobutt JM, Kaspar RE, Li HY, Kwak JW, Hopp K, Weiser-Evans MCM, Heasley LE, Schenk EL, Clambey ET, Nemenoff RA. Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma. Journal of Immunology (Baltimore, Md. : 1950). PMID 32179637 DOI: 10.4049/Jimmunol.1900778 |
0.42 |
|
| 2019 |
Sippel TR, Johnson AM, Li HY, Hanson D, Nguyen TT, Bullock BL, Poczobutt JM, Kwak JW, Kleczko EK, Weiser-Evans MC, Nemenoff RA. Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors Through TGF-β1. Molecular Cancer Research : McR. PMID 31088909 DOI: 10.1158/1541-7786.Mcr-19-0236 |
0.459 |
|
| 2019 |
Poczobutt JM, Eickelberg O. Defining the Cell Types That Drive IPF Using Single Cell RNA Sequencing. American Journal of Respiratory and Critical Care Medicine. PMID 30715901 DOI: 10.1164/Rccm.201901-0197Ed |
0.314 |
|
| 2018 |
Tippimanchai DD, Nolan K, Poczobutt J, Verzosa G, Li H, Scarborough H, Huang J, Young C, DeGregori J, Nemenoff RA, Malkoski SP. Adenoviral vectors transduce alveolar macrophages in lung cancer models. Oncoimmunology. 7: e1438105. PMID 29872579 DOI: 10.1016/J.Jtho.2017.06.056 |
0.398 |
|
| 2018 |
Li HY, McSharry M, Walker D, Johnson A, Kwak J, Bullock B, Neuwelt A, Poczobutt JM, Sippel TR, Keith RL, Weiser-Evans MCM, Clambey E, Nemenoff RA. Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II. Oncoimmunology. 7: e1423182. PMID 29721380 DOI: 10.1080/2162402X.2017.1423182 |
0.411 |
|
| 2017 |
Kwak JW, Laskowski J, Li HY, McSharry MV, Sippel TR, Bullock BL, Johnson AM, Poczobutt JM, Neuwelt AJ, Malkoski SP, Weiser-Evans MC, Lambris J, Clambey ET, Thurman JM, Nemenoff RA. Complement activation via a C3a receptor pathway alters CD4+ T lymphocytes and mediates lung cancer progression. Cancer Research. PMID 29118090 DOI: 10.1158/0008-5472.Can-17-0240 |
0.376 |
|
| 2017 |
Li HY, McSharry MV, Bullock B, Nguyen TT, Kwak J, Poczobutt JM, Sippel TR, Heasley LE, Weiser-Evans MC, Clambey ET, Nemenoff RA. The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PDL1 Antibody Blockade. Cancer Immunology Research. PMID 28819064 DOI: 10.1158/2326-6066.Cir-16-0365 |
0.349 |
|
| 2016 |
Majesky MW, Horita H, Ostriker A, Lu S, Regan JN, Bagchi AK, Dong XR, Poczobutt JM, Nemenoff RA, Weiser-Evans MC. Differentiated Smooth Muscle Cells Generate a Subpopulation of Resident Vascular Progenitor Cells in the Adventitia Regulated by KLF4. Circulation Research. PMID 27834190 DOI: 10.1161/Circresaha.116.309322 |
0.35 |
|
| 2016 |
Poczobutt JM, De S, Yadav VK, Nguyen TT, Li H, Sippel TR, Weiser-Evans MC, Nemenoff RA. Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung Cancer. Journal of Immunology (Baltimore, Md. : 1950). PMID 26873985 DOI: 10.4049/Jimmunol.1502364 |
0.373 |
|
| 2015 |
Poczobutt JM, Nguyen TT, Hanson D, Li H, Sippel TR, Weiser-Evans MC, Gijon M, Murphy RC, Nemenoff RA. Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell Recruitment. Journal of Immunology (Baltimore, Md. : 1950). PMID 26663781 DOI: 10.4049/Jimmunol.1501648 |
0.439 |
|
| 2013 |
Poczobutt JM, Gijon M, Amin J, Hanson D, Li H, Walker D, Weiser-Evans M, Lu X, Murphy RC, Nemenoff RA. Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. Plos One. 8: e79633. PMID 24244531 DOI: 10.1371/Journal.Pone.0079633 |
0.423 |
|
| 2011 |
Li H, Sorenson AL, Poczobutt J, Amin J, Joyal T, Sullivan T, Crossno JT, Weiser-Evans MC, Nemenoff RA. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. Plos One. 6: e28133. PMID 22145026 DOI: 10.1371/Journal.Pone.0028133 |
0.469 |
|
| 2011 |
Prescott JD, Poczobutt JM, Tentler JJ, Walker DM, Gutierrez-Hartmann A. Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism. Molecular Cancer. 10: 103. PMID 21871131 DOI: 10.1186/1476-4598-10-103 |
0.623 |
|
| 2010 |
Poczobutt JM, Tentler J, Lu X, Schedin PJ, Gutierrez-Hartmann A. Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells. Bmc Cancer. 10: 373. PMID 20637104 DOI: 10.1186/1471-2407-10-373 |
0.694 |
|
| 2010 |
Walker DM, Poczobutt JM, Gonzales MS, Horita H, Gutierrez-Hartmann A. ESE-1 is Required to Maintain the Transformed Phenotype of MCF-7 and ZR-75-1 Human Breast Cancer Cells The Open Cancer Journal. 3: 77-88. DOI: 10.2174/1874079001003010077 |
0.688 |
|
| 2010 |
Walker DM, Poczobutt JM, Gonzales MS, Horita H, Gutierrez-Hartmann A. ESE-1 is required to maintain the transformed phenotype of MCF-7 and ZR-75-1 human breast cancer cells Open Cancer Journal. 3: 77-88. |
0.503 |
|
| 2009 |
Schweppe RE, Kerege AA, Sharma V, Poczobutt JM, Gutierrez-Hartmann A, Grzywa RL, Haugen BR. Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition. Thyroid : Official Journal of the American Thyroid Association. 19: 825-35. PMID 19500021 DOI: 10.1089/Thy.2008.0362 |
0.606 |
|
| Show low-probability matches. |